{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-22T08:21:17.456388+00:00","published_at":"2026-10-22T04:46:54.636037+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:cd9ygh1j7y3mf","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:person:james-huang","alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"James Huang seat on Atara Biotherapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16vzh7i77k9iq","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:person:nachi-subramanian","alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"Nachi Subramanian seat on Atara Biotherapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1nxmlsm1wa9ck2","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:committee:atara-biotherapeutics-inc:nominating-and-governance-chair","alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"Nominating and Governance · Chair committee of Atara Biotherapeutics, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1g2curns1dmx3","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:person:nachi-subramanian","alpha:committee:atara-biotherapeutics-inc:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"Nachi Subramanian member of Nominating and Governance · Chair, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15mgrz81831pd8","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:person:anhco-nguyen-ph-d","alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"AnhCo Nguyen, Ph.D. seat on Atara Biotherapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hb177b18ryn5n","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:person:gregory-a-ciongoli","alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"Gregory A. Ciongoli seat on Atara Biotherapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1l4qk5i16f2t1w","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:person:gregory-a-ciongoli","alpha:committee:atara-biotherapeutics-inc:nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:committee_record:16"],"evidence_ids":["alpha:projection-evidence:5fabbf66cbbe3753ba1bf7695dc1ea23bc0ff7d9c020c8926d301018fb2b54d8"],"summary":"Gregory A. Ciongoli member of Nominating and Governance, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:182lfag1lqrwiu","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:person:william-k-heiden","alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"William K. Heiden seat on Atara Biotherapeutics, Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3ygp1cmc0iwe","event_type":"COMMITTEE_CREATED","effective_at":"2015-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:committee:atara-biotherapeutics-inc:audit-nominating-and-governance-chair","alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"Audit; Nominating and Governance · Chair committee of Atara Biotherapeutics, Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:35fjc93sx9t7","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2015-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:person:william-k-heiden","alpha:committee:atara-biotherapeutics-inc:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"William K. Heiden member of Audit; Nominating and Governance · Chair, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:l8rzbb191zzat","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:person:matthew-k-fust","alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"Matthew K. Fust seat on Atara Biotherapeutics, Inc., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1f6cssb1teya4l","event_type":"COMMITTEE_CREATED","effective_at":"2014-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:committee:atara-biotherapeutics-inc:audit-chair","alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"Audit · Chair committee of Atara Biotherapeutics, Inc., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:jwqnji1o2kxru","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2014-01-01","detected_at":"2026-10-22T04:46:54.636037+00:00","subject_ids":["alpha:person:matthew-k-fust","alpha:committee:atara-biotherapeutics-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031"],"summary":"Matthew K. Fust member of Audit · Chair, effective 2014-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:7","subject_id":"alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:anhco-nguyen-ph-d","object_label":"AnhCo Nguyen, Ph.D.","object_source_name_forms":[],"value":"AnhCo Nguyen, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:anhco-nguyen-ph-d","name":"AnhCo Nguyen, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-22T04:46:54.636037+00:00","sources":[{"id":"alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Atara Biotherapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000119312526177285/atra-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:13:00.521+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-22T04:46:54.636037+00:00","reviewed_at":"2026-10-22T04:46:54.636037+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:8","subject_id":"alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gregory-a-ciongoli","object_label":"Gregory A. Ciongoli","object_source_name_forms":[],"value":"Gregory A. Ciongoli: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gregory-a-ciongoli","name":"Gregory A. Ciongoli"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-22T04:46:54.636037+00:00","sources":[{"id":"alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Atara Biotherapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000119312526177285/atra-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:13:00.521+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-22T04:46:54.636037+00:00","reviewed_at":"2026-10-22T04:46:54.636037+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:9","subject_id":"alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-huang","object_label":"James Huang","object_source_name_forms":[],"value":"James Huang: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-huang","name":"James Huang"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-22T04:46:54.636037+00:00","sources":[{"id":"alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Atara Biotherapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000119312526177285/atra-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:13:00.521+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-22T04:46:54.636037+00:00","reviewed_at":"2026-10-22T04:46:54.636037+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:10","subject_id":"alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:matthew-k-fust","object_label":"Matthew K. Fust","object_source_name_forms":[],"value":"Matthew K. Fust: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:matthew-k-fust","name":"Matthew K. Fust"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-22T04:46:54.636037+00:00","sources":[{"id":"alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Atara Biotherapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000119312526177285/atra-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:13:00.521+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-22T04:46:54.636037+00:00","reviewed_at":"2026-10-22T04:46:54.636037+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:11","subject_id":"alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:nachi-subramanian","object_label":"Nachi Subramanian","object_source_name_forms":[],"value":"Nachi Subramanian: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:nachi-subramanian","name":"Nachi Subramanian"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-22T04:46:54.636037+00:00","sources":[{"id":"alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Atara Biotherapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000119312526177285/atra-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:13:00.521+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-22T04:46:54.636037+00:00","reviewed_at":"2026-10-22T04:46:54.636037+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:leadership_role:12","subject_id":"alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:william-k-heiden","object_label":"William K. Heiden","object_source_name_forms":[],"value":"William K. Heiden: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:william-k-heiden","name":"William K. Heiden"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-22T04:46:54.636037+00:00","sources":[{"id":"alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Atara Biotherapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000119312526177285/atra-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:13:00.521+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-22T04:46:54.636037+00:00","reviewed_at":"2026-10-22T04:46:54.636037+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f:committee_record:16","subject_id":"alpha:company:f23c27a4-e4f1-438f-af71-bda0a9d5a23f","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Nachi Subramanian; William K. Heiden; Members Nachi Subramanian (Chair); William K. Heiden (Chair); Gregory A. Ciongoli","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Nachi Subramanian; William K. Heiden","members":[{"display_name":"Nachi Subramanian","person_slug":"nachi-subramanian","is_chair":true},{"display_name":"William K. Heiden","person_slug":"william-k-heiden","is_chair":true},{"display_name":"Gregory A. Ciongoli","person_slug":"gregory-a-ciongoli","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-22T04:46:54.636037+00:00","sources":[{"id":"alpha:projection-evidence:5fabbf66cbbe3753ba1bf7695dc1ea23bc0ff7d9c020c8926d301018fb2b54d8","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1604464/000119312526177285/atra-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-22T04:46:54.636037+00:00","reviewed_at":"2026-10-22T04:46:54.636037+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:52184c0ea0aa62e8ac5c6700c810659b55ae28bb522d619a9bd2e3c242cde031","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Atara Biotherapeutics, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000119312526177285/atra-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T23:13:00.521+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:5fabbf66cbbe3753ba1bf7695dc1ea23bc0ff7d9c020c8926d301018fb2b54d8","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1604464/000119312526177285/atra-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.821,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.795,"cross_source_agreement":0.75,"temporal_completeness":0.545},"diagnostics":{"published_claims":19,"factual_claims":19,"claims_with_linked_evidence":19,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":11,"temporal_claims_with_valid_from":6,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-22T04:46:54.636037+00:00","observed_at":"2026-10-22T04:46:54.636037+00:00","reviewed_at":"2026-10-22T04:46:54.636037+00:00","verified_at":"2026-10-22T04:46:54.636037+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/atara-biotherapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/atara-biotherapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}